Literature DB >> 25859366

Cocaine and kidney injury: a kaleidoscope of pathology.

Narender Goel1, James M Pullman2, Maria Coco3.   

Abstract

Cocaine is abused worldwide as a recreational drug. It is a potent activator of the sympathetic nervous system leading to intense vasoconstriction, endothelial dysfunction, oxidative stress, platelet activation and decrease in prostaglandins E2 and prostacyclin. Cocaine can lead to widespread systemic adverse effects such as stroke, myocardial infarction, arterial dissection, vascular thrombosis and rhabdomyolysis. In human and rat kidneys, cocaine has been associated with glomerular, tubular, vascular and interstitial injury. It is not uncommon to diagnose cocaine-related acute kidney injury (AKI), malignant hypertension and chronic kidney disease. Cocaine abuse can lead to AKI by rhabdomyolysis, vasculitis, infarction, thrombotic microangiopathy and malignant hypertension. It is reported that 50-60% of people who use both cocaine and heroin are at increased risk of HIV, hepatitis and additional risk factors that can cause kidney diseases. While acute interstitial nephritis (AIN) is a known cause of AKI, an association of AIN with cocaine is unusual and seldom reported. We describe a patient with diabetes mellitus, hypertension and chronic hepatitis C, who presented with AKI. Urine toxicology was positive for cocaine and a kidney biopsy was consistent with AIN. Illicit drugs such as cocaine or contaminants may have caused AIN in this case and should be considered in the differential diagnosis of causes of AKI in a patient with substance abuse. We review the many ways that cocaine adversely impacts on kidney function.

Entities:  

Keywords:  AIN; AKI; cocaine; vasoconstriction

Year:  2014        PMID: 25859366      PMCID: PMC4389131          DOI: 10.1093/ckj/sfu092

Source DB:  PubMed          Journal:  Clin Kidney J        ISSN: 2048-8505


Background

Cocaine, also known as benzoyl methyl ecgonine, is a tropane alkaloid found in erythroxylon coca leaves. Cocaine is widely abused worldwide despite being banned since early 19th century. As per the World Health Organization, the lifetime prevalence of cocaine abuse is 1% worldwide and 3% in developed countries, with higher rates in the USA [1]. Recent reports suggest that as of 2011, 17 million people across the world have used cocaine at least once in the last year [2]. Cocaine causes systemic adverse effects such as stroke, myocardial infarction, dissection, vascular thrombosis and rhabdomyolysis, and is associated with renal complications such as acute kidney injury (AKI), malignant hypertension and chronic kidney disease (CKD) [3, 4]. Cocaine abuse also poses challenges during pregnancy and kidney transplantation. Cocaine can cause a kaleidoscope of renal pathology. As illicit drugs are frequently contaminated with adulterants which can have additional mechanisms of kidney injury, acute interstitial nephritis (AIN), though unusual, should be included in the differential diagnosis of AKI.

Case report

A 49-year-old male with history of diabetes mellitus, hypertension, chronic hepatitis C and substance abuse presented with nausea, vomiting and decreased oral intake for 1 week. He was afebrile and normotensive. He had no rash, pericardial rub, edema or asterixis. His home medications included atorvastatin, gabapentin, metformin, insulin, metoclopramide and ibuprofen 800 mg four times a day for 2 weeks prior to admission. He later confirmed the ongoing use of intravenous cocaine as urine toxicology screen was positive for cocaine, methadone and opiates. Admission chemistries showed AKI [serum creatinine: 1080 µmol/L (12.2 mg/dL)], normal creatine phosphokinase [CPK] (45 U/L) and insignificant peripheral eosinophil count (3%). Urinalysis showed a specific gravity of 1.014, pH 7.0, a significant amount of blood but no protein and negative nitrite. Urine microscopy showed 9 RBC per high-power field, 70 WBC per high-power field and eosinophils but no casts. Urine culture was negative. Renal sonogram showed normal-sized kidneys without hydronephrosis or calculus. As the patient had refractory hyperkalemia, hemodialysis was initiated. Serologic workup such as ANA, ANCA, anti-GBM antibody, hepatitis B and HIV were negative. Complement levels [C3 (1.4 g/L) and C4 (0.33 g/L)] were normal. A kidney biopsy performed on Day 14 showed 11 glomeruli with mild mesangial expansion but no crescents. Podocytes were normal. Tubules were 95% intact without acute injury, and arteries were normal. The interstitium showed edema, scattered clusters of eosinophils with a few neutrophils, largely confined to the medulla, and no fibrosis, all consistent with a diagnosis of AIN, likely drug related, with illicit drug or adulterants as possible etiology. The patient was started on oral prednisone 60 mg daily. With gradual renal recovery, hemodialysis was discontinued and he was discharged home 9 days after kidney biopsy on oral prednisone with a serum creatinine of 310 µmol/L (3.5 mg/dL). The patient presented a week later with a history of anuria for 1 day after repeated intravenous cocaine use. Laboratory data again showed AKI [serum creatinine 1060 µmol/L (12 mg/dL), hyperkalemia (potassium 7 mmol/L), normal CPK (37 U/L) but high WBC count of 35 × 109/L. Hemodialysis was again required, now for 21 days after readmission. Steroids were tapered off as the hospital course was complicated by acute bacterial endocarditis requiring aortic valve replacement. He was again discharged with renal recovery [creatinine 265 µmol/L (3 mg/dL)]. The patient returned several weeks later, again following a cocaine binge, with AKI. He was returned to dialysis. He eventually succumbed to multi-organ failure.

Discussion

In this case, the kidney biopsy was consistent with AIN with interstitial edema and scattered clusters of eosinophils. Serologic evaluation did not suggest acute glomerulonephritis, while urinalysis showed sterile pyuria and eosinophiluria. As described by Perazella et al., AIN induced by NSAIDs occurs after prolonged exposure (several months) and interstitial infiltrates are usually not eosinophilic [5]; hence ibuprofen use as the cause for AIN, though not definitively excluded, was less likely. It is unclear whether cocaine itself or the adulterant could have caused AIN. Nevertheless, regardless of the agent involved, AIN should be considered in the differential diagnosis of kidney injury in a patient with substance abuse. His second and third presentations of AKI followed further cocaine exposure, which favored cocaine as the likely trigger, although the clinical course was greatly complicated by infective endocarditis and multi-system organ failure which could have had additional mechanisms for causing AKI independent for cocaine. This case illustrates the complexities involved in the diagnosis of kidney injury in the setting of cocaine abuse due to various possibilities of underlying pathology. Cocaine can be abused via the oral, intravenous, inhalation or intranasal route. Currently available forms of cocaine are water soluble cocaine hydrochloride (powdered form) which can be snorted or used intravenously and water insoluble cocaine base (freebase) or crack cocaine which is used via the inhalation route [6].

Pathophysiology of cocaine effects

Cocaine is a sympathomimetic and acts by blocking the uptake of serotonin, norepinephrine and dopamine in presynaptic nerve terminals [7]. It blocks voltage-specific sodium channels which impart a local anesthetic property [7]. Cocaine can cause endothelial dysfunction and promote oxidative stress and platelet aggregation, all of which can lead to kidney injury. Sympathetic activation: Cocaine induces intense activation of the sympathetic nervous system by blocking the uptake of norepinephrine and stimulating central sympathetic outflow [8] and causing vasoconstriction by impairing nitric oxide-mediated vasodilation [9]. Endothelium: Cocaine has been shown to increase plasma and urinary endothelin-1 [10], a potent vasoconstrictor produced by endothelial cells. Cocaine impairs endothelium-dependent vasorelaxation [11]. Both of these actions can result in altered vascular homeostasis. Cocaine stimulates transforming growth factor-β production by inhibiting interleukin-8 expression, resulting in further endothelial cell dysfunction [12]. Platelet activation: In a randomized, double-blind cross-over trial, healthy humans were exposed to intranasal cocaine versus placebo. An over-expression of platelet factor 4 and β-thromboglobulin, and stimulated formation of platelet-containing microaggregates were noted with cocaine exposure [13]. Rinder et al. showed that some cocaine users had higher levels of activated platelets by promoting platelet α-granule release via an unclear mechanism [14]. Activated platelets can activate leukocytes by binding and forming a platelet-leukocyte complex which produces chemokines, further facilitating leukocyte recruitment, monocyte adhesion, inflammation and endothelial dysfunction [15]. In rats, inhibition of platelet-activating factor was shown to be protective against ischemic-reperfusion injury [16]. Prostaglandin pathways: Prostaglandin pathways play a crucial role in maintaining stable systemic and renal vascular homeostasis. Some members of the pathway such as prostaglandin E2, a direct vasodilator, and prostacyclin (prostaglandin I2), a platelet aggregation inhibitor in addition to being a direct vasodilator, were decreased in a dose-dependent manner in cultures of first-passaged endothelial cells from human umbilical cord, when these cells were incubated with various doses of cocaine [17]. Oxidative stress: When metabolized, cocaine forms reactive oxygen species and contributes to oxidative stress leading to mitochondrial respiration inhibition, intracellular glutathione depletion and cell death [18]. Cocaine metabolizes into benzoylecgonine, ecgonine methyl ester and norcocaine [19]. Norcocaine metabolites, which include nitroxide, nitrosonium and iminium [20], play a crucial role in oxidative stress and reactive oxygen species (ROS) generation and lipid peroxidation. In the primary cultured proximal tubular epithelial cell, norcocaine induced nephrotoxicity and apoptosis [19]. Cocaine also increases superoxide dismutase activity in various tissues and lipid peroxidation in rat kidneys, as measured by malondialdehyde levels [21].

Nephropathology of cocaine

Rats exposed to intraperitoneal cocaine developed significant glomerular, vascular, tubular and interstitial damage encompassing glomerular atrophy, glomerular sclerosis, mesangial cell proliferation, capillary loop thrombosis and rupture, capillary basement membrane thickening, tubular epithelial cell swelling and necrosis, interstitium with foci of necrosis and hemorrhage [22]. Cocaine interacts with macrophages and modulates mesangial cell proliferation via interleukin-6 and transforming growth factor-β [23]. It also may stimulate immunoglobulin G (IgG) aggregation in the mesangium and glomeruli [24]. In a series of 40 autopsies, it was noted that glomerular hyalinosis and periglomerular fibrosis was significantly higher in cocaine addicts when compared with controls. There was also a higher degree of arteriolar sclerosis, intimal and medial thickness and circumference [25], suggesting chronic adverse effects of cocaine on glomerulus and vasculature. In a postmortem analysis of 129 deceased illicit drug abusers, cocaine exposure was significantly associated with glomerular ischemia, arteriosclerosis and hypertensive-ischemic nephropathy [26]. Cocaine accelerates atherogenesis [27] and activates the renin-angiotensin-aldosterone system. It enhances the renal cortical mRNA expression of tissue inhibitors of metalloproteinase-2 and leads to increased matrix accumulation [28]. Cocaine is mainly associated with AKI which can require renal replacement therapy. It is important for clinicians to be aware of the mechanisms of cocaine-induced AKI as these can be highly variable as illustrated in multiple case reports (Table 1). Evidence linking cocaine, CKD and end-stage renal disease (ESRD) is limited. It is reported that 50–60% of people who use both cocaine and heroin [29] are at increased risk of HIV, hepatitis, additional risk factors that cause kidney disease.
Table 1.

Spectrum of renal injury related to cocaine

Clinical presentationEstablished causesPathophysiologyNephropathology
Acute kidney injury [25, 28, 3544]Rhabdomyolysis [30, 31]Skeletal myofibrillar degeneration, muscle ischemia. Necrosis, seizure, hyperpyrexia [32]Renal vasoconstriction [9, 11], free radical generation [1821], endothelin receptor activation, direct cytotoxicity, intraluminal cast formation [32, 33]
Vasculitis [34, 35, 36]Adulterant as levamisole [34], leukoclastic vasculitis [34, 35]Myeloperoxidase and anti-proteinase 3 ANCA vasculitis [37], anti-GBM vasculitis [38]
Thrombotic microangiopathy and malignant HTN [46]Sympathetic activation [7, 8], platelet activation [1315, 47], endothelial injury [15]Aortic thrombosis [38], renal arterial thrombosis [40], dissection [41], microangiopathy
Infarction [27, 3941]Platelet aggregation [27], thromboxane synthesis stimulation [27]Renal vasoconstriction [9, 11], thrombosis [40, 41], dissection [36]
Chronic kidney disease [26, 29]Mesangial and glomerular IgG aggregation [24], atherogenesis [27], RAAS activation [27], increased matrix accumulation [28]Glomerular atrophy, sclerosis [22], periglomerular fibrosis [25], mesangial cell proliferation [23], basement membrane thickening [22], tubular epithelial swelling and necrosis [22]
Hypertension [48, 49]Sympathetic activation [7, 8], increased endothelin [10], endothelial injury [15], activation of RAAS [27]Arterial sclerosis, intimal and medial thickness and circumference [25]

ANCA, anti-neutrophilic cytoplasmic antibody; GBM, glomerular basement membrane; RAAS, renin-angiotensin aldosterone system; HTN, hypertension.

Acute kidney injury (AKI) Rhabdomyolysis: There are several cases reports suggesting cocaine-induced rhabdomyolysis and resultant renal failure [30, 31]. Proposed mechanisms of cocaine-induced rhabdomyolysis include non-traumatic injury due to direct toxicity of cocaine leading to acute skeletal myofibrillar degeneration and vasoconstriction leading to muscle ischemia and necrosis, or traumatic due to seizure or hyperpyrexia [32]. Once myoglobin is released it has the potential to cause AKI by renal vasoconstriction, free radical generation, direct cytotoxicity, intraluminal cast formation, acute tubular necrosis, activation of endothelin receptor and negating the effect of vasodilatory nitric oxide [32, 33]. It is interesting to note that several of these rhabdomyolysis-related renal injury mechanisms are shared by the direct effects of cocaine as well. Thus cocaine and rhabdomyolysis are the double jeopardy for AKI. Vasculitis: It is estimated that 69% of cocaine is adulterated with levamisole [34], an immunomodulatory drug used as an anti-helminthic drug in animals but withdrawn from the markets due to severe side effects such as agranulocytosis [34, 35] and leukoclastic vasculitis. Levamisole is being used as a cutting and bulking agent and thought to potentiate the effect of cocaine by stimulating the sympathetic nervous system as an agonist for nicotinic acetylcholine receptor. Additionally, it potentiates the effect of increased release of dopamine due to cocaine [36]. Levamisole is proposed to be the mediator of cocaine-induced vasculitis [36]. A case series of 30 patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in relation with cocaine and likely levamisole [37] has been reported. These patients with AAV were all positive for a characteristic several fold higher titer of myeloperoxidase (MPO) ANCA titer and 50% also had co-existent anti-proteinase 3 ANCA (PR-3 ANCA). Additionally, many patients also had antinuclear antibody positivity and low complements. A case report has also speculated that anti-glomerular basement membrane disease could be associated with cocaine [38]. Infarction: Renal infarction (Figure 1) in association with cocaine has been well described [27, 39–41]. Its pathophysiology includes vasoconstriction and thrombosis mediated by cocaine-induced stimulation of platelet aggregation and thromboxane synthesis [27]. Acute aortic thrombosis [40], renal artery thrombosis [41] and even dissection [41] in association with cocaine have been described.
Fig. 1.

Computerized tomography showing areas of focal decreased enhancement of the anterior lower poles (white arrow) of the right kidney suggesting renal infarction (Figure taken from reference [27] with permission).

Acute Interstitial Nephritis (AIN): Recently, a few case reports have been published suggesting a link between AIN and cocaine exposure in patients presenting with AKI and cocaine abuse [42–44, 45]. It is unclear whether cocaine in itself or contaminants could be involved. However, this association of cocaine and AIN underlies an additional novel mechanism of AKI related to the drug. Thrombotic microangiopathy and malignant hypertension: Cocaine use has been associated thrombotic microangiopathy with accelerated and malignant hypertension which has the potential to cause significant renal injury [46]. A prothrombotic effect of cocaine has been suggested by case reports of aortic, renal artery and renal venous thrombosis culminating in renal failure. Endothelial injury and platelet activation are proposed mechanisms [47]. Chronic kidney disease: Evidence linking cocaine, CKD and ESRD is limited. It is reported that 50–60% of people who use both cocaine and heroin [29] are at increased risk of HIV, hepatitis, additional risk factors that cause kidney disease. Hypertension: In a review of 301 black male patients admitted for cocaine addiction treatment, the drug was associated with acute hypertension but not with chronic hypertension or albuminuria [48, 49], although, it was associated with hypertension in HIV patients [50]. Pregnancy and fetal kidney: Cocaine abuse during pregnancy may have adverse effects on the fetal kidney. Studies have suggested a decrease in fetal arterial flow, urine output, bladder cycle, higher resistance index of the renal artery, thickening of the interlobular arterial wall of the fetal kidney and luminal narrowing [51, 52]. Kidney transplantation: In an analysis of Scientific Registry of Transplant Recipients (SRTR) data on kidneys from deceased donors, the odds of rejection of extended donor kidney were significantly higher with donor cocaine abuse, although in the lower kidney donor risk index (1.4–1.6) category only [53]. Successful transplantation of a kidney from a patient who died from cocaine abuse has been reported [54]. Active substance abuse including cocaine is a relative contraindication for kidney transplantation, and kidney recipients are required to abstain from substance abuse for at least 6 months. Spectrum of renal injury related to cocaine ANCA, anti-neutrophilic cytoplasmic antibody; GBM, glomerular basement membrane; RAAS, renin-angiotensin aldosterone system; HTN, hypertension. Computerized tomography showing areas of focal decreased enhancement of the anterior lower poles (white arrow) of the right kidney suggesting renal infarction (Figure taken from reference [27] with permission).

Conclusion

In conclusion, kidney injury associated with cocaine can have variable underlying causes and requires the physician to have knowledge of possible pathophysiological mechanisms to be able to define an appropriate diagnosis and make a decision regarding further treatment.

Conflict of interest statement

None declared.
  52 in total

1.  Kidney vascular damage and cocaine.

Authors:  N Di Paolo; V Fineschi; M Di Paolo; C V Wetly; G Garosi; M T Del Vecchio; G Bianciardi
Journal:  Clin Nephrol       Date:  1997-05       Impact factor: 0.975

2.  Illicit drug use, hypertension, and chronic kidney disease in the US adult population.

Authors:  Sanjeev K Akkina; Ana C Ricardo; Amishi Patel; Arjun Das; Lydia A Bazzano; Carolyn Brecklin; Michael J Fischer; James P Lash
Journal:  Transl Res       Date:  2012-06-23       Impact factor: 7.012

3.  Antiglomerular basement membrane antibody-mediated glomerulonephritis after intranasal cocaine use.

Authors:  R Peces; R A Navascués; J Baltar; M Seco; J Alvarez
Journal:  Nephron       Date:  1999       Impact factor: 2.847

4.  Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy.

Authors:  E P Havranek; K Nademanee; P A Grayburn; E J Eichhorn
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

5.  Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer.

Authors:  Peter Kovacic
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

6.  An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury.

Authors:  K J Kelly; N E Tolkoff-Rubin; R H Rubin; W W Williams; S M Meehan; C L Meschter; J G Christenson; J V Bonventre
Journal:  Am J Physiol       Date:  1996-11

7.  Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge.

Authors:  Kachiu C Lee; Barry Ladizinski; Daniel G Federman
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

8.  Myoglobinuric acute renal failure associated with cocaine use.

Authors:  E A Turbat-Herrera
Journal:  Ultrastruct Pathol       Date:  1994 Jan-Apr       Impact factor: 1.094

9.  Platelet alpha-granule release in cocaine users.

Authors:  H M Rinder; K A Ault; P I Jatlow; T R Kosten; B R Smith
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

10.  Oxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaine.

Authors:  Lucyna Pomierny-Chamioło; Andrzej Moniczewski; Karolina Wydra; Agata Suder; Małgorzata Filip
Journal:  Neurotox Res       Date:  2012-07-12       Impact factor: 3.911

View more
  8 in total

1.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

2.  M1 and M3 muscarinic receptors may play a role in the neurotoxicity of anhydroecgonine methyl ester, a cocaine pyrolysis product.

Authors:  Raphael Caio Tamborelli Garcia; Livia Mendonça Munhoz Dati; Larissa Helena Torres; Mariana Aguilera Alencar da Silva; Mariana Sayuri Berto Udo; Fernando Maurício Francis Abdalla; José Luiz da Costa; Renata Gorjão; Solange Castro Afeche; Mauricio Yonamine; Colleen M Niswender; P Jeffrey Conn; Rosana Camarini; Maria Regina Lopes Sandoval; Tania Marcourakis
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

3.  Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.

Authors:  Carmine Rossi; Joseph Cox; Curtis Cooper; Valérie Martel-Laferrière; Sharon Walmsley; John Gill; Ruth Sapir-Pichhadze; Erica E M Moodie; Marina B Klein
Journal:  AIDS       Date:  2016-06-01       Impact factor: 4.177

Review 4.  Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Authors:  Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

5.  Spectrum of acute kidney injury associated with cocaine use: report of three cases.

Authors:  José Célio Costa Lima Filho; Maurício Yukio Ogawa; Tacilla Hanny de Souza Andrade; Sami de Andrade Cordeiro Gadelha; Paula Frassinetti Castelo Branco Camurça Fernandes; Anaiara Lucena Queiroz; Elizabeth De Francesco Daher
Journal:  BMC Nephrol       Date:  2019-03-20       Impact factor: 2.388

6.  Cocaine nephropathy: A rare cause of abnormal nephrograms.

Authors:  Hannah Lamberg; Richard H Cohan; John D Millet
Journal:  Radiol Case Rep       Date:  2021-01-17

Review 7.  Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects including Abuse Pattern.

Authors:  Rita Roque Bravo; Ana Carolina Faria; Andreia Machado Brito-da-Costa; Helena Carmo; Přemysl Mladěnka; Diana Dias da Silva; Fernando Remião
Journal:  Toxins (Basel)       Date:  2022-04-13       Impact factor: 5.075

Review 8.  Cocaine-Induced Acute Interstitial Nephritis: A Comparative Review of 7 Cases.

Authors:  Faisal Inayat; Syed Rizwan A Bokhari; Lisa Roberts; Raquel M Rosen
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.